Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06322693
Title	A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	GlaxoSmithKline
Indications	hepatocellular carcinoma lung non-squamous non-small cell carcinoma lung non-small cell carcinoma lung squamous cell carcinoma
Therapies	Cobolimab + Docetaxel Cisplatin + Cobolimab + Dostarlimab-gxly + Pemetrexed Disodium Cobolimab + Docetaxel + Dostarlimab-gxly Cobolimab + Dostarlimab-gxly Cobolimab Cobolimab + Dostarlimab-gxly + TSR-033 Cobolimab + Nivolumab
Age Groups:	adult \| senior
Covered Countries	USA \| ESP